Patents by Inventor Glenn A. Goldstein

Glenn A. Goldstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240296196
    Abstract: A computing device is configured to perform acts that include displaying a graphical user interface (GUI) of an operating system installed on the computing device, where a taskbar of the GUI includes a search box. The search box includes: 1) a text entry field that is configured to receive textual input; and 2) a graphical icon. The acts also include detecting a selection of the text entry field and presenting a first graphical pane on the display in response to detecting the selection of the text entry field, where the first graphical pane includes first content. The acts also include detecting a selection of the graphical icon. The acts further include presenting a second graphical pane on the display in response to detecting the selection of the graphical icon, where the second graphical pane comprises second content that is different from the first content.
    Type: Application
    Filed: May 13, 2024
    Publication date: September 5, 2024
    Inventors: Katie Elizabeth GOLDSTEIN, Katherine Chen LEE, Ilda Marie LADEIRA, Pavi BHATTER, Allan Joseph BONIFACIO, Chelsea LE, Alexander Leo CAMPBELL, Bradford Glenn SINGLEY, Zhe LIU, Houman MOTEVASELOLHAGH, Arthur Li-Pang CHEN, Dena Natalie SAUNDERS
  • Patent number: 10869846
    Abstract: Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione.
    Type: Grant
    Filed: April 2, 2018
    Date of Patent: December 22, 2020
    Assignee: SENTIENT LIFESCIENCES, INC.
    Inventor: Glenn A. Goldstein
  • Publication number: 20200170968
    Abstract: This disclosure describes methods of use for N-acetylcysteine amide for the treatment of HIV infection and AIDS.
    Type: Application
    Filed: July 3, 2019
    Publication date: June 4, 2020
    Inventor: GLENN A. GOLDSTEIN
  • Publication number: 20200069617
    Abstract: This disclosure describes pharmaceutical compositions and methods of use for N-acetylcysteine amide for the prevention and treatment of acetaminophen overdose.
    Type: Application
    Filed: May 30, 2019
    Publication date: March 5, 2020
    Inventor: Glenn A. Goldstein
  • Publication number: 20200038349
    Abstract: This disclosure describes methods of use for N-acetylcysteine amide for the treatment of penetrating head injury.
    Type: Application
    Filed: March 6, 2019
    Publication date: February 6, 2020
    Inventor: Glenn A. Goldstein
  • Patent number: 10547886
    Abstract: A device, system, and method synthesizes personalized linear television experiences from on-demand assets, live event video, streaming graphics, and dynamic ad insertion, where portions of the broadcast day are scheduled for globally shared viewing events, where other portions are scheduled for distinct programming for various audience segments. Vector graphics are streamed independently of the video and rasterized locally to improve quality and contextualization of the graphics layer while gaining the efficiency of leveraging the same cached video assets for linear and on-demand applications.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: January 28, 2020
    Assignee: Viacom International Inc.
    Inventors: Gregg William Riedel, Glenn Goldstein
  • Publication number: 20190388369
    Abstract: This disclosure describes methods of use for N-acetylcysteine amide for the treatment of various disorders
    Type: Application
    Filed: January 25, 2019
    Publication date: December 26, 2019
    Inventor: Glenn A. Goldstein
  • Publication number: 20190151262
    Abstract: This disclosure describes methods of use for N-acetylcysteine amide for the treatment of penetrating head injury.
    Type: Application
    Filed: June 18, 2018
    Publication date: May 23, 2019
    Inventor: GLENN A. GOLDSTEIN
  • Publication number: 20190111009
    Abstract: Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione.
    Type: Application
    Filed: April 2, 2018
    Publication date: April 18, 2019
    Inventor: Glenn A. Goldstein
  • Publication number: 20190082207
    Abstract: A device, system, and method synthesizes personalized linear television experiences from on-demand assets, live event video, streaming graphics, and dynamic ad insertion, where portions of the broadcast day are scheduled for globally shared viewing events, where other portions are scheduled for distinct programming for various audience segments. Vector graphics are streamed independently of the video and rasterized locally to improve quality and contextualization of the graphics layer while gaining the efficiency of leveraging the same cached video assets for linear and on-demand applications.
    Type: Application
    Filed: November 13, 2018
    Publication date: March 14, 2019
    Inventors: Gregg William RIEDEL, Glenn GOLDSTEIN
  • Patent number: 10165316
    Abstract: A device, system, and method synthesizes personalized linear television experiences from on-demand assets, live event video, streaming graphics, and dynamic ad insertion, where portions of the broadcast day are scheduled for globally shared viewing events, where other portions are scheduled for distinct programming for various audience segments. Vector graphics are streamed independently of the video and rasterized locally to improve quality and contextualization of the graphics layer while gaining the efficiency of leveraging the same cached video assets for linear and on-demand applications.
    Type: Grant
    Filed: March 31, 2016
    Date of Patent: December 25, 2018
    Assignee: VIACOM INTERNATIONAL INC.
    Inventors: Gregg William Riedel, Glenn Goldstein
  • Publication number: 20170289597
    Abstract: A device, system, and method synthesizes personalized linear television experiences from on-demand assets, live event video, streaming graphics, and dynamic ad insertion, where portions of the broadcast day are scheduled for globally shared viewing events, where other portions are scheduled for distinct programming for various audience segments. Vector graphics are streamed independently of the video and rasterized locally to improve quality and contextualization of the graphics layer while gaining the efficiency of leveraging the same cached video assets for linear and on-demand applications.
    Type: Application
    Filed: March 31, 2016
    Publication date: October 5, 2017
    Inventors: Gregg William RIEDEL, Glenn GOLDSTEIN
  • Publication number: 20170135970
    Abstract: Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione.
    Type: Application
    Filed: October 21, 2016
    Publication date: May 18, 2017
    Inventor: Glenn A. Goldstein
  • Publication number: 20170049727
    Abstract: This disclosure describes methods of use for N-acetylcysteine amide for the treatment of HIV infection and AIDS.
    Type: Application
    Filed: February 12, 2015
    Publication date: February 23, 2017
    Inventor: Glenn A. Goldstein
  • Publication number: 20170000747
    Abstract: This disclosure describes pharmaceutical compositions and methods of use for N-acetylcysteine amide for the prevention and treatment of acetaminophen overdose.
    Type: Application
    Filed: June 6, 2016
    Publication date: January 5, 2017
    Inventor: Glenn A. Goldstein
  • Publication number: 20160206576
    Abstract: Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione.
    Type: Application
    Filed: October 23, 2015
    Publication date: July 21, 2016
    Inventor: Glenn A. Goldstein
  • Patent number: 9216162
    Abstract: Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione.
    Type: Grant
    Filed: February 26, 2015
    Date of Patent: December 22, 2015
    Inventor: Glenn A. Goldstein
  • Publication number: 20150164830
    Abstract: Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione.
    Type: Application
    Filed: February 26, 2015
    Publication date: June 18, 2015
    Inventor: Glenn A. Goldstein
  • Publication number: 20150148423
    Abstract: This disclosure describes methods of use for N-acetylcysteine amide for the treatment of various disorders
    Type: Application
    Filed: April 26, 2013
    Publication date: May 28, 2015
    Applicant: SENTIENT LIFESCIENCES, INC.
    Inventor: Glenn A. Goldstein
  • Publication number: 20150133558
    Abstract: This disclosure describes methods of use for N-acetylcysteine amide for the treatment of penetrating head injury.
    Type: Application
    Filed: October 15, 2014
    Publication date: May 14, 2015
    Inventor: Glenn A. Goldstein